WHO naming stem · suffix · 222 listed names
-tinib
tyrosine kinase inhibitors
Where it sits in a name
WHO writes the stem as -tinib. So the letters tinib sit at the end of the name (…tinib).
All 222 names WHO lists under -tinib
These are the INN in group (a) of Part IV of the stem book: names in which WHO says the stem is used as defined. The stem is marked where WHO places it. A-Z as WHO lists them.
- abivertinib
- abrocitinib
- acalabrutinib
- adrixetinib
- afatinib
- alectinib
- altiratinib
- amuvatinib
- anizatrectinib
- ansornitinib
- atinvicitinib
- atuzabrutinib
- aumolertinib
- avapritinib
- avutometinib
- axitinib
- bafetinib
- baricitinib
- befotertinib
- belizatinib
- bemcentinib
- beprocitinib
- bezuclastinib
- binimetinib
- boditrectinib
- bosutinib
- branebrutinib
- brigatinib
- cabozantinib
- canertinib
- capmatinib
- catequentinib
- cerdulatinib
- ceritinib
- cobimetinib
- conteltinib
- crizotinib
- dacomitinib
- dalmelitinib
- darizmetinib
- dasatinib
- decernotinib
- defactinib
- delgocitinib
- denfivontinib
- derazantinib
- deucravacitinib
- deuruxolitinib
- dovitinib
- dubermatinib
- ebezotinib
- edicotinib
- edralbrutinib
- elenestinib
- elsubrutinib
- elzovantinib
- emzeltrectinib
- ensartinib
- entospletinib
- entrectinib
- epertinib
- erdafitinib
- erlotinib
- evobrutinib
- famitinib
- fedratinib
- fenebrutinib
- filgotinib
- fisogatinib
- flumbatinib
- foretinib
- fosifidancitinib
- fostamatinib
- fruquintinib
- futibatinib
- gandotinib
- gefitinib
- gemnelatinib
- gilteritinib
- glesatinib
- golidocitinib
- golvatinib
- gumarontinib
- gunagratinib
- gusacitinib
- ibrutinib
- ifebemtinib
- ifidancitinib
- ilginatinib
- ilunocitinib
- imatinib
- infigratinib
- itacitinib
- ivarmacitinib
- izencitinib
- lapatinib
- larotrectinib
- lazertinib
- lenvatinib
- lestaurtinib
- linsitinib
- lirafugratinib
- lorlatinib
- lorpucitinib
- luxeptinib
- masitinib
- mavelertinib
- merestinib
- mifanertinib
- milrebrutinib
- mirdametinib
- mivavotinib
- mobocertinib
- momelotinib
- mubritinib
- naquotinib
- narmafotinib
- nazartinib
- nemtabrutinib
- neratinib
- nezulcitinib
- nilotinib
- nimucitinib
- oclacitinib
- olafertinib
- olverembatinib
- orantinib
- orelabrutinib
- osimertinib
- pacritinib
- paltimatrectinib
- pamufetinib
- peficitinib
- pegcantratinib
- pelitinib
- pemigatinib
- pexidartinib
- pexmetinib
- pirtobrutinib
- ponatinib
- poseltinib
- povorcitinib
- poziotinib
- pralsetinib
- pumecitinib
- quizartinib
- radotinib
- ralimetinib
- rebastinib
- refametinib
- remibrutinib
- repotrectinib
- resencatinib
- rezivertinib
- rilzabrutinib
- ripretinib
- risvodetinib
- ritlecitinib
- roblitinib
- rociletinib
- rogaratinib
- ropsacitinib
- rovadicitinib
- ruserontinib
- ruxolitinib
- sacibertinib
- sapitinib
- saracatinib
- savolitinib
- selitrectinib
- selpercatinib
- selumetinib
- seralutinib
- sitravatinib
- sofnobrutinib
- solcitinib
- sotuletinib
- spebrutinib
- sunitinib
- sunvozertinib
- surufatinib
- taletrectinib
- tamnorzatinib
- tandutinib
- tarloxotinib bromide
- tasurgratinib
- telatinib
- tepotinib
- tesevatinib
- tinengotinib
- tirabrutinib
- tivantinib
- tofacitinib
- tolebrutinib
- trametinib
- tucatinib
- tunlametinib
- tuspetinib
- tuxobertinib
- unecritinib
- upadacitinib
- utatrectinib
- vamotinib
- varlitinib
- vebreltinib
- vecabrutinib
- vepafestinib
- vimseltinib
- vodobatinib
- xiliertinib
- zanubrutinib
- zanzalintinib
- zapnometinib
- zasocitinib
- zeteletinib
- zidesamtinib
- zipalertinib
- zoligratinib
- zongertinib
- zorifertinib
- zunsemetinib
- zurletrectinib
Decode another name
Decoded
afatinib
Listed INNCarries the WHO stem -tinib
- -tinibend of the nameWHO lists it hereWHO definition: tyrosine kinase inhibitors
“afatinib” is an INN that WHO lists under -tinib in the 2024 stem book.
The same decoder as the front page: it reads the letters of a name against all 482 WHO stems, in your browser.
Source and licence
The definition of -tinib (Part II B) and the 222 names (Part IV, group (a)) are from Use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances, 2024 (World Health Organization, Stem book 2024 (ISBN 978-92-4-009938-8); covers proposed INN Lists 1-129). Checked .
Adapted from: Use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances, 2024. Geneva: World Health Organization; 2024. Licence: CC BY-NC-SA 3.0 IGO. This adaptation was not created by WHO; WHO is not responsible for its content or accuracy and does not endorse this site. The data file stems.json is shared under the same licence.